FDA Import Refusal 9F2-7129697-0/21/1 — Dottikon Exclusive Synthesis AG
The FDA refused shipment 9F2-7129697-0/21/1 from Dottikon Exclusive Synthesis AG (Switzerland) on October 11, 2022. The refused product falls under Drugs and Biologics — ANTI-NEOPLASTIC N.E.C.. Cited charge: 118 This firm has 3 other import refusals on record.
Refusal Details
- Date
- October 11, 2022
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 62ICY99 ANTI-NEOPLASTIC N.E.C.
- Charges
- 118